首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged constitutively active mutant G-protein-coupled receptor
【2h】

Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged constitutively active mutant G-protein-coupled receptor

机译:通过监测海肾荧光素酶标记的组成型活性突变体G蛋白偶联受体的选择性稳定来检测受体配体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">The wild-type β2-adrenoceptor and a constitutively active mutant of this receptor were C-terminally tagged with luciferase from the sea pansy Renilla reniformis.C-terminal addition of Renilla luciferase did not substantially alter the levels of expression of either form of the receptor, the elevated constitutive activity of the mutant β2-adrenoceptor nor the capacity of isoprenaline to elevate cyclic AMP levels in intact cells expressing these constructs.Treatment of cells expressing constitutively active mutant β2-adrenoceptor-Renilla luciferase with antagonist/inverse agonist ligands resulted in upregulation of levels of this polypeptide which could be monitored by the elevated luciferase activity.The pEC50 for ligand-induced luciferase upregulation and ligand affinity to bind the receptor were highly correlated.Similar upregulation could be observed following sustained treatment with agonist ligands.These effects were only observed at a constitutively active mutant of the β2-adrenoceptor. Co-expression of the wild-type β2-adrenoceptor C-terminally tagged with the luciferase from Photinus pyralis did not result in ligand-induced upregulation of the levels of activity of this luciferase.Co-expression of the constitutively active mutant β2-adrenoceptor-Renilla luciferase and an equivalent mutant of the α1b-adrenoceptor C-terminally tagged with green fluorescent protein allowed pharmacological selectivity of adrenoceptor antagonists to be demonstrated.This approach offers a sensitive and convenient means, which is amenable to high throughput analysis, to monitor ligand binding to a constitutively active mutant receptor.As no prior knowledge of receptor ligands is required this approach may be suitable to identify ligands at orphan G protein-coupled receptors.
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 野生型β2-肾上腺素能受体和该受体的组成型活性突变体被海堇三色海肾Renilla reniformis的荧光素酶C末端标记。两种形式的受体的表达,突变型β2-肾上腺素受体的组成性活性的升高,或异丙肾上腺素提高表达这些构建体的完整细胞中环AMP水平的能力。 表达组成型活性突变体β2的细胞的治疗-肾上腺素受体-肾性荧光素酶与拮抗剂/反向激动剂配体的结合导致该多肽水平的上调,这可以通过荧光素酶活性的升高来监测。 pEC50对配体诱导的荧光素酶上调和配体亲和力的结合受体高度相关。 这些作用仅在β2-肾上腺素受体的组成型活性突变体上观察到。与Photinus pyralis萤光素酶共同标记的野生型β2-肾上腺素受体C-末端的共表达不会导致配体诱导的这种萤光素酶活性水平的上调。 组成性活性突变体β2-肾上腺素受体肾小球荧光素酶和等效的突变体C-末端标记有绿色荧光蛋白,可以证明肾上腺素受体拮抗剂的药理选择性。 这种方法提供了一种灵敏且方便的方法可以进行高通量分析的方法,用于监测配体与组成型活性突变受体的结合。 由于不需要受体配体的先验知识,该方法可能适合于鉴定孤儿G蛋白的配体-偶联受体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号